Please note that this content was created in 2018. In the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.
AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at educate.amp.org. The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.
This is a recording of a session from AMP Europe 2018 meeting in Rotterdam. Purchase the entire AMP Europe 2018 Recordings for a significant discount!
This session focuses on how characterizing and monitoring tumor genomes with biological fluid-base samples could achieve significant improvements in precision medicine. As tumors shed parts of themselves into the circulation, analyses of circulating tumor cells, circulating tumor DNA, and tumor-derived exosomes, often referred to as "liquid biopsies", may enable tumor genome characterization by minimally invasive means. As data accumulates and test performance continues to improve, exciting applications are on the horizon for faster disease detection, earlier disease diagnosis, and the ability to track disease progression and provide more efficient treatment response. The presenters will bring together the most up-to-date information and the current state-of-the-field for liquid biopsy as well as identify current challenges and solutions.
CANCER-ID: European Network for Validation of Liquid Biopsy Tests
Anna Babayan (Hamburg, Germany)
Personalized Liquid Biopsy: Applications in Colorectal, Bladder, Breast, Lung and Beyond
C. Jimmy Lin (San Carlos, USA)
Objectives:
- Understand how to apply liquid biopsies for the advancement of precision medicine.
- Evaluate the scope of clinical utility for liquid biopsies in cancer.
- Understand the current challenges and possible solutions for the implantation of liquid biopsy in cancer management.
Duration: 1.00 hr
Recording Date: April 30, 2018
Last day to purchase: December 31, 2021
There are no CME/CMLE or SAMs credits available.Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
